GENESCO INC

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Net sales $2.9b $2.9b $2.2b $2.2b $1.8b $2.4b $2.4b $2.3b $2.3b $2.4b
Cost of sales $1.5b $1.5b $1.1b $1.1b $982.1m $1.2b $1.2b $1.2b $1.2b $1.3b
Operating income (loss) $142.0m ($96.2m) $81.8m $83.3m ($107.2m) $155.6m $93.2m ($13.5m) $13.9m $17.3m
Gross margin $1.0b $1.0b $1.1b $804.5m $1.2b $1.1b $1.1b $1.1b $1.1b
Goodwill impairment $0 $182.2m $0 $0 $79.3m $0 $0 $28.5m $0 $0
Asset impairments and other, net ($802k) $8.8m $3.2m $13.4m $18.7m ($8.1m) $855k $1.8m $3.2m $8.1m
Earnings (loss) from continuing operations before income taxes $151.4m ($101.7m) $78.3m $82.4m ($111.7m) $153.0m $90.1m ($21.8m) $9.3m $12.6m
Earnings (loss) from continuing operations $97.9m ($111.4m) $51.2m $61.8m ($56.0m) $114.9m $72.2m ($23.6m) ($19.5m) $13.3m
Gain (loss) from discontinued operations, net of tax $24.5m ($148.5m) ($103.2m) ($373k) ($401k) ($97k) ($327k) $6.8m $622k ($7k)
Net Earnings (Loss) $5 ($6) ($3) $4 ($4) $8 $6 ($2) ($2) $1
Basic (in shares) $19.2m $19.4m $15.5m $14.2m $14.2m $12.5m $11.2m $10.8m $10.4m
Diluted (in shares) $19.3m $19.5m $15.7m $14.2m $14.5m $12.7m $11.2m $10.8m $10.6m
Continuing operations (in dollars per share) $4.85 ($5.80) $2.63 $3.94 ($3.94) $7.92 $5.69 ($2.10) ($1.80) $1.25
Discontinued operations (in dollars per share) ($0.02) ($0.02) ($5.29) ($0.02) ($0.03) $0.00 ($0.03) $0.60 $0.06 $0.00
Selling and administrative expenses $1.3b $1.3b $962.1m $966.4m $813.8m $1.0b $1.0b $1.1b $1.1b $1.1b
Other components of net periodic benefit cost $2.1m ($29k) ($380k) ($395k) ($670k) $128k $248k $537k $367k $625k
Interest expense (net of interest income of $0.7 million, $0.7 million and $0.4 million for Fiscal 2026, 2025 and 2024, respectively) $5.2m $5.4m $3.3m $1.3m $5.1m $2.4m $2.9m $7.8m $4.2m $4.1m
Income tax expense (benefit) $53.6m $9.8m $27.0m $20.7m ($55.6m) $38.0m $17.8m $1.9m $28.8m ($685k)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.